BostonGene
Business Services · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
95 Sawyer Rd Ste 500, Waltham, Massachus...Phone Number
(617) 658-4545Website
www.bostongene.comRevenue
$94.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About BostonGene
BostonGene's mission is to power healthcare's transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. BostonGene Tumor PortraitTM Testsreveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene Tumor PortraitTM Tests generate a personalized roadmap for therapeutic decision-making for each cancer patient.Explore more
BostonGene Org Chart
JF
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BostonGene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BostonGene is spiking on competitors!
Check if BostonGene has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when BostonGene launches new products
Earning: See what the market has to say on BostonGene recently announced quarterly report
Funding: Get notified immidiatlly once BostonGene has new funding data
Website visits: Recent activity has been detected on your website
Click to see if BostonGene had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BostonGene
BostonGene, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at BostonGene
Find 3 more new buyers
Compare Similar Companies to BostonGene
Compare insights from companies similar to BostonGene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
Company Profile Activity
Activity Insights
BostonGene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BostonGene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BostonGene.
BostonGene financials insights
Gather financial insights about BostonGene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$50M
2022
Series B
$150M
BostonGene Tech Stack
A closer look at the technologies used by BostonGene
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals, Artificial Intelligence, Clinical Operations
Open Position
Hiring Plans
BostonGene has more open roles in Marketing than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Person-Based
Medical Research, Pharmaceuticals
BostonGene News & Media
Texas Medical Center Appoints Ferran Prat to Board of Directors - TMC
Located in the heart of Houston, Texas Medical Center campus is home to leaders in research, medicine, and innovation in healthcare.BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions
Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global...BostonGene and Kyoto University link on oesophageal cancer drug
The research expands upon the investigator-initiated Phase II Nobel clinical study led by Dr Manabu Muto of Kyoto University.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BostonGene
Sign Up For FreeTo access detailed company insights
BostonGene's mission is to power healthcare's transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. BostonGene Tumor PortraitTM Testsreveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomar... Read More
